ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 83 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 205.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $62,000 | +37.8% | 36,600 | 0.0% | 0.00% | – |
Q4 2020 | $45,000 | -13.5% | 36,600 | 0.0% | 0.00% | – |
Q3 2020 | $52,000 | -38.8% | 36,600 | -48.2% | 0.00% | – |
Q2 2020 | $85,000 | +107.3% | 70,600 | +104.6% | 0.00% | – |
Q1 2020 | $41,000 | -8.9% | 34,500 | +61.2% | 0.00% | – |
Q4 2019 | $45,000 | -4.3% | 21,400 | 0.0% | 0.00% | – |
Q3 2019 | $47,000 | -13.0% | 21,400 | 0.0% | 0.00% | – |
Q2 2019 | $54,000 | -1.8% | 21,400 | +50.7% | 0.00% | – |
Q1 2015 | $55,000 | +14.6% | 14,200 | +97.2% | 0.00% | – |
Q4 2014 | $48,000 | -35.1% | 7,200 | -46.3% | 0.00% | – |
Q3 2014 | $74,000 | -46.0% | 13,400 | 0.0% | 0.00% | – |
Q2 2014 | $137,000 | – | 13,400 | +60809.1% | 0.00% | – |
Q1 2014 | $0 | -100.0% | 22 | -97.3% | 0.00% | – |
Q4 2013 | $9,000 | -96.2% | 822 | -96.3% | 0.00% | – |
Q3 2013 | $239,000 | +8.1% | 22,222 | -6.6% | 0.00% | – |
Q2 2013 | $221,000 | – | 23,805 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 6,574,060 | $25,376,000 | 1.97% |
SENZAR ASSET MANAGEMENT, LLC | 1,040,681 | $4,017,000 | 0.98% |
Cormorant Asset Management, LP | 850,000 | $3,281,000 | 0.51% |
Palo Alto Investors LP | 2,135,739 | $8,244,000 | 0.41% |
Opus Point Partners Management, LLC | 99,959 | $386,000 | 0.32% |
Granahan Investment Management | 1,527,837 | $5,897,000 | 0.17% |
WALL STREET ASSOCIATES | 367,200 | $1,417,000 | 0.13% |
CAXTON CORP | 21,870 | $84,000 | 0.10% |
SHEPHERD KAPLAN KROCHUK, LLC | 107,392 | $415,000 | 0.07% |
Joel Isaacson & Co., LLC | 70,660 | $273,000 | 0.07% |